Liver transplantation for ductopenia after thiabendazole administration;Transplantation hepatique pour ductopenie severe associee la prise de thiabendazole

Gastroenterologie Clinique et Biologique

Volumn 21, Issue 8-9, 1997, Pages 623-625

  Skandrani, Karim ^a   Richardet, Jean Philippe ^a   Duvoux, Christophe ^a   Cherqui, Daniel ^a   Zafrani, Elie Serge ^a   Dhumeaux, Daniel ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Chronic cholestasis; Drug induced hepatitis; Liver transplantation; Sicca syndrome; Thiabendazole

Indexed keywords

TIABENDAZOLE; ANTINEMATODAL AGENT;

ADULT; ARTICLE; CASE REPORT; CHOLESTASIS; DISEASE ASSOCIATION; ESOPHAGUS VARICES; HUMAN; JAUNDICE; LIVER BIOPSY; LIVER TRANSPLANTATION; MALE; SJOEGREN SYNDROME; STRONGYLOIDIASIS; ANIMAL; BILIARY CIRRHOSIS; CHEMICALLY INDUCED DISORDER; STRONGYLOIDES STERCORALIS; TOXIC HEPATITIS;

ADULT; ANIMALS; ANTINEMATODAL AGENTS; CHOLESTASIS; HEPATITIS, TOXIC; HUMANS; LIVER CIRRHOSIS, BILIARY; LIVER TRANSPLANTATION; MALE; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; THIABENDAZOLE;

EID: 0030885811     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Hennekeuser HH, Pabst K, Poeplau W, Gerok W. Thiabendazole for the treatment of trichinosis in humans. Texas Rep Biol Med 1969;27(suppl2):581-96.
2. Bayles MAH. Chromomycosis: treatment with thiabendazole. Arch Dermatol 1971;104:476-85.
3. Jalota R, Freston JW. Severe intrahepatic cholestasis due to thiabendazole. Am J Trop Med Hyg 1974;23:676-8.
4. Feregrino GM, Lifshitz GA, Hemandez BA, Ramirez DJ, Cervantes LF. Coléstasis intrahepatic por thiabendazol tratada con fenobarbital. Prensa Med Mex 1976;41:167-71.
5. Fink AI, MacKay CJ, Cutler SS. Sicca complex and cholangiostatic jaundice in two members of a family probably caused by thiabendazole. Ophtalmology 1979;86:1892-6.
6. Rex D, Lumeng L, Eble J, Rex L. Intrahepatic cholestasis and sicca complex after thiabendazole. Gastroemerology 1983;85:718-21.
7. Manivel JC, Bloomer JR, Snover DC. Progressive bile duct injury after thiabendazole administration. Gastroenterology 1987;93:245-9.
8. Davidson RN, Weir WRC, Kaye GL. Intrahepatic cholestasis after thiabendazole. Trans R Soc Trop Med Hyg 1988;82:620.
9. Roy MA, Nugent FW, Aretz HT. Micronodular cirrhosis after thiabendazole. Dig Dis Sei 1989;34:938-41.
10. Bion E, Pariente EA, Maître F. Severe cholestasis and sicca syndrome after thiabendazole. J Hepatol 1995:23:762-3.
11. Larrey D, Michel H. Pathologie biliaire due aux médicaments. Gastroenterol Clin Biol 1993;17:H59-65.
12. Cavanzo FJ, Garcia CF, Bolero RC. Chronic cholestasis, paucity of bile ducts, red cell aplasia, and the Stevens-Johnson syndrome. An ampicillin-associated case. Gastroenterology 1990;99:854-6.
13. Degott C, Feldmann G, Larrey D, Durand-Schneider AM, Grange D, Machayekhi JP, et al. Drug-induced prolonged cholestasis in adults: a histological semiquantitative study demonstrating progressive ductopenia. Hepatology 1992;15:244-51.
14. Speed BR, Spelman DW. Sialadenitis and systemic reaction associated with phenylbutazone. Aust NZ J Med 1982; 12:261-4.
15. Hautekeete ML, Brenard R, Horsmans Y, Henrion J, Verbist L, Derue G, et al. Liver injury related to amoxycillin-clavulanic acid: interlobular bile-duct lesions and extrahepatic manifestations. J Hepatol 1995;22:71-7.
16. Piotrowicz A, Polkey M, Wilkinson M. Ursodeoxycholic acid for the treatment of flucloxacillin - associated cholestasis. J Hepatol 1995:22:119-20.